Prospective Research Rare Kidney Stones (ProRKS)

RecruitingOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
HyperoxaluriaCystinuriaDent DiseaseLowe SyndromeAdenine Phosphoribosyltransferase Deficiency
Trial Locations (11)

10010

NOT_YET_RECRUITING

New York University, New York

19104

NOT_YET_RECRUITING

Children's Hospital of Philadelphia, Philadelphia

32224

NOT_YET_RECRUITING

Mayo Clinic Jacksonville, Jacksonville

35294

NOT_YET_RECRUITING

University of Alabama @ Birmingham, Birmingham

45229

NOT_YET_RECRUITING

Cincinnati Children's Hosptial Medical Center, Cincinnati

55905

RECRUITING

Mayo Clinic Hyperoxaluria Center, Rochester

60614

NOT_YET_RECRUITING

Children's Memorial Hospital, Chicago

02115

NOT_YET_RECRUITING

Children's Hospital, Harvard Medical School, Boston

M5G 1X8

NOT_YET_RECRUITING

Hosptial of Sick Children, Toronto

Unknown

NOT_YET_RECRUITING

Landspitali Universtiy Hospital, Reykjavik

NOT_YET_RECRUITING

Shaare Zedek Medica Center, Jerusalem

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT02780297 - Prospective Research Rare Kidney Stones (ProRKS) | Biotech Hunter | Biotech Hunter